lncRNA MALAT1 potentiates the progression of tongue squamous cell carcinoma through regulating miR-140-5p-PAK1 pathway

被引:36
|
作者
Zhu, Minhui [1 ]
Zhang, Caiyun [1 ]
Chen, Donghui [1 ]
Chen, Shicai [1 ]
Zheng, Hongliang [1 ]
机构
[1] Second Mil Med Univ, Changhai Hosp, Dept Otorhinolaryngol Head & Neck Surg, 168 Changhai Rd, Shanghai 200433, Peoples R China
来源
ONCOTARGETS AND THERAPY | 2019年 / 12卷
基金
中国国家自然科学基金;
关键词
tongue squamous cell carcinoma; lncRNA; MALAT1; miRNA-140-5p; PAK1; NONCODING RNA; HEPATOCELLULAR-CARCINOMA; CANCER STATISTICS; INVASION; GROWTH; MICRORNA-140-5P; METASTASIS;
D O I
10.2147/OTT.S192069
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Tongue squamous cell carcinoma (TSCC) is the second most common malignancy in oral carcinoma. lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) was regarded as an oncogcnic factor in various carcinomas. However, its underlying molecular mechanisms in the development and progression of TSCC have not been well featured till now. Methods: The expressions of MALAT1, miR-140-5p and p21 (RAC1)-activated kinase 1 (PAK1) mRNA were measured by RT-qPCR assay. The protein level of PAK1 was determined by western blot analysis. Cell viability was detected by Cell Counting Kit-8 assay. Transwell chamber was used to detect cell migratory and invasive capability. Luciferase reporter assay, RNA-binding protein immunoprecipitation (RIP) assay and biotin pull-down assay were applied to evaluate the relationship between MALAT1,miR-140-5p and PAK1. Xenograft experiments were performed to assess the effect and mechanism of MALAT1 in TSCC tumor growth. Results: The expression ofMALAT1 and p21 (RAC1)-activated kinase 1 (PAK1) was upregulated and micro RN A-140-5p (miR-140-5p) expression was downregulated in TSCC tissues and cells. MALAT1 knockdown induced miR-140-5p expression by direct interaction. Moreover, MALAT1 knockdown inhibited proliferation, migration, and invasion by upregulating miR-140-5p expression in TSCC cells. Additionally, PAK1 was identified as a direct target of miR-140-5p. Also, MALAT1 knockdown inhibited PAK1 expression by upregulating miR-140-5p in TSCC cells. Furthermore, miR-I40-5p overexpression curbed the proliferation, migration, and invasion of TSCC cells by targeting PAK1. Finally, MALAT1 knockdown inhibited tumor growth by upregulating miR-140-5p and downregulating PAK1 in mouse xenograft models of TSCC. Conclusion: MALAT1 contributed to TSCC progression via miR-140-5p-PAK1 regulatory axis, highlighting a potential target for TSCC management.
引用
收藏
页码:1365 / 1377
页数:13
相关论文
共 50 条
  • [1] LncRNA MALAT1 Regulating Lung Carcinoma Progression via the miR-491-5p/UBE2C Axis
    Dai, Juanjuan
    Zhou, Ning
    Wu, Rui
    Du, Jing
    Miao, Shuang
    Gong, Kaikai
    Yang, Lijuan
    Chen, Weiwei
    Li, Xuelin
    Li, Chen
    Wu, Yan
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [2] LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis
    Cao, Yongxian
    Zhang, Feng
    Wang, Haotian
    Bi, Chunhua
    Cui, Jinpeng
    Liu, Fenghai
    Pan, Huazheng
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2021, 476 (01) : 279 - 292
  • [3] LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis
    Yongxian Cao
    Feng Zhang
    Haotian Wang
    Chunhua Bi
    Jinpeng Cui
    Fenghai Liu
    Huazheng Pan
    Molecular and Cellular Biochemistry, 2021, 476 : 279 - 292
  • [4] lncRNA MALAT1 promotes cell proliferation and invasion by regulating the miR-101/EZH2 axis in oral squamous cell carcinoma
    Xiao, Lei
    Wang, Weiping
    Zhao, Jingjing
    Xu, Hongyan
    Li, Shaozhen
    Yang, Xiuhua
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [5] LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p
    Yue, Xin
    Wu, Wen-ying
    Dong, Ma
    Guo, Meng
    BIOMEDICAL JOURNAL, 2021, 44 (06) : S296 - S304
  • [6] Interaction between miR-206 and lncRNA MALAT1 in regulating viability and invasion in hepatocellular carcinoma
    Wang, Jun
    Yao, Guoliang
    Zhang, Beike
    Zhao, Zerui
    Fan, Yonggang
    ONCOLOGY LETTERS, 2024, 27 (01)
  • [7] Glyoxalase 1, regulated by LncRNA MALAT1, promotes malignant development of esophageal squamous cell carcinoma
    Guo, Zhong
    Hu, Liwen
    Luo, Jing
    Xu, Yang
    Diao, Yifei
    Ji, Saiguang
    Cong, Zhuangzhuang
    Shen, Yi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (05): : 2337 - 2346
  • [8] LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p/HMGB1 axis
    Wu, Qiong
    Meng, Wen-Ying
    Jie, Ying
    Zhao, Haijian
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (09) : 6750 - 6757
  • [9] Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma
    Wang, Zhujuan
    Chang, Xiong
    Zhu, Guannan
    Gao, Xiaoting
    Chang, Luyuan
    CELL CYCLE, 2020, 19 (16) : 2054 - 2062
  • [10] lncRNA MALAT1 promotes chondrocyte proliferation by inhibiting MiR-127-5p
    Shen, Chengchun
    Gan, Kaifeng
    Zhang, Feng
    Huang, Lei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (06): : 3978 - 3988